SUBSTITUTES APPENDIX A OF THE OMAC 1999 OLYMPIC MOVEMENT ANTI-DOPING CODE APPENDIX A PROHIBITED CLASSES OF SUBSTANCES AND PROHIBITED METHODS 1 January 2003 PROHIBITED CLASSES OF SUBSTANCES
A. STIMULANTS
a
Prohibited substances in class A.a include the following examples with both their L- and D-isomers amiphenazole, amphetamines, bromantan, caffeine*, carphedon, cocaine, ephedrines**, fencamfamin, mesocarb, pentetrazol, pipradrol, . and related substances.
* For caffeine the definition of a positive is a concentration in urine greater
** For ephedrine and methylephedrine, the definition of a positive is a
concentration in urine greater than 10 micrograms per millilitre. For cathine, the definition of a positive is a concentration in urine greater than 5 micrograms per millilitre. For phenylpropanolamine and pseudoephedrine, the definition of a positive is a concentration in urine greater than 25 micrograms per millilitre. NOTE: All imidazole preparations are acceptable for topical use. Vasoconstrictors may be administered with local anaesthetic agents. Topical preparations (e.g. nasal, ophthalmological, rectal) of adrenaline are permitted. Bupropion, synephrine and phenylephrine are permitted b
Prohibited substances in class A.b include the following examples with both their L- and D-isomers formoterol***, salbutamol***, salmeterol*** and terbutaline*** … and related substances
*** permitted by inhaler only to prevent and/or treat asthma and exercise-induced asthma. Written notification by a respiratory or team physician that the athlete has asthma and/or exercise-induced asthma is necessary to the relevant medical authority prior to competition. At the Olympics Games, athletes who request permission to inhale a permitted beta-2 agonist, will be assessed by an independent medical panel. B. NARCOTICS
Prohibited substances in class (B) include the following examples: buprenorphine, dextromoramide, diamorphine (heroin), methadone, morphine, pentazocine, pethidine,. and related substances. NOTE: codeine, dextromethorphan, dextropropoxyphene, dihydrocodeine, diphenoxylate, ethylmorphine, pholcodine, propoxyphene and tramadol are permitted. C. ANABOLIC AGENTS
Prohibited substances in class (C) include the following examples: 1. Anabolic androgenic steroids
a.
clostebol, fluoxymesterone, metandienone, metenolone, nandrolone, 19-norandrostenediol, 19-norandrostenedione, oxandrolone, stanozolol, . and related substances. b. androstenediol, androstenedione, dehydroepiandrosterone (DHEA), dihydrotestosterone, testosterone*, . and related substances.
Evidence obtained from metabolic profiles and/or isotopic ratio measurements
may be used to draw definitive conclusions.
* The presence of a testosterone (T) to epitestostrone (E) ratio greater than
six (6) to one (1) in the urine of a competitor constitutes an offence unless there is evidence that this ratio is due to a physiological or pathological condition, e.g. low epitestosterone excretion, androgen producing tumour, enzyme deficiencies.
In the case of T/E greater than 6, it is mandatory that the relevant medical
authority conducts an investigation before the sample is declared positive. A full report will be written and will include a review of previous tests, subsequent tests and any results of endocrine investigations. In the event that previous tests are not
available, the athlete should be tested unannounced at least once per month for three months. The results of these investigations should be included in the report. Failure to co-operate in the investigations will result in declaring the sample positive. 2. Other anabolic agents
clenbuterol, salbutamol *
* For salbutamol, a concentration in urine greater than 1000 nanograms per
millilitre of non-sulphated salbutamol constitutes a doping violation. D. DIURETICS
Prohibited substances in class (D) include the following examples: acetazolamide, bumetanide, chlortalidone, etacrynic acid, furosemide, hydrochlorothiazide, mannitol*, mersalyl, spironolactone, triamterene, . and related substances.
E. PEPTIDE HORMONES, MIMETICS AND ANALOGUES
Prohibited substances in class (E) include the following examples and their analogues and mimetics:
1. Chorionic Gonadotrophin (hCG) prohibited in males only; 2. Pituitary and synthetic gonadotrophins (LH) prohibited in males only; 3. Corticotrophins(ACTH, tetracosactide); 4. Growth hormone (hGH); 5. Insulin-like Growth Factor (IGF-1); and all the respective releasing factors
6. Erythropoietin (EPO); 7. Insulin*
*permitted only to treat athletes with certified insulin-dependent diabetes.
The term ‘insulin-dependent’ is used here to describe people with diabetes in whom insulin treatment is required, in the judgement of a suitably qualified physician. It will always be the case in Type 1 and sometimes in Type 2 diabetes mellitus. Written certification of insulin-dependent diabetes must be obtained from an endocrinologist or team physician.
The presence of an abnormal concentration of an endogenous hormone in
class (E) or its diagnostic marker(s) in the urine of a competitor constitutes an offence unless it has been proven to be due to a physiological or pathological condition. F. AGENTS WITH ANTI-OESTROGENIC ACTIVITY Aromatase inhibitors, clomiphene, cyclofenil, tamoxifen are prohibited only in males. G. MASKING AGENTS
Prohibited substances in class (G) include the following examples: diuretics, epitestosterone*, probenecid, plasma expanders (e.g . hydroxyethyl starch) Masking agents are prohibited. They are products that have the potential to impair the excretion of prohibited substances or to conceal their presence in urine or other samples used in doping control.
* The presence of a urinary concentration of epitestosterone greater than 200
ng/mL constitutes an anti-doping violation unless there is evidence that it is due to a physiological condition. Isotopic ratio mass spectrometry (IRMS) may be used to draw definitive conclusions. If the results of the IRMS are inconclusive, the relevant medical authority shall conduct an investigation before the sample is declared positive.
II. PROHIBITED
The following procedures are prohibited:
A. ENHANCEMENT OF OXYGEN TRANSFER
a. Blood doping. Blood doping is the administration of autologous,
homologous or heterologous blood or red blood cell products of any origin, other than for legitimate medical treatment.
b. The administration of products that enhance the uptake, transport or
delivery of oxygen, e.g. modified haemoglobin products including but not limited to bovine and cross-linked haemoglobins, microencapsulated haemoglobin products, perfluorochemicals, and RSR13.
B. PHARMACOLOGICAL, CHEMICAL AND PHYSICAL MANIPULATION
Pharmacological, chemical and physical manipulation is the use of substances and methods, including masking agents (ref I . G), which alter, attempt to alter or may reasonably be expected to alter the integrity and validity of specimens collected in doping controls. These include, without limitation, catheterisation, urine substitution and/or tampering, inhibition of renal excretionand alterations of testosterone and epitestosterone (ref I. G) measurements. C. GENE DOPING
Gene or cell doping is defined as the non-therapeutic use of genes, genetic elements and/or cells that have the capacity to enhance athletic performance. CLASSES OF PROHIBITED SUBSTANCES IN CERTAIN SPORTS
A. ALCOHOL
Where the rules of the governing body so provide, tests will be conducted for ethanol. B. CANNABINOIDS
Where the rules of the governing body so provide, tests will be conducted for cannabinoids (e.g. Marijuana, Hashish). At the Olympic Games, tests will be conducted for cannabinoids. A concentration in urine of 11-nor-delta 9- tetrahydrocannabinol-9-carboxylic acid (carboxy-THC) greater than 15 nanograms per millilitre constitutes doping. C. LOCAL ANAESTHETICS
Injectable local anaesthetics are permitted under the following conditions:
a. bupivacaine, lidocaine, mepivacaine, procaine, and related substances, can
be used but not cocaine. Vasoconstrictor agents may be used in conjunction with local anaesthetics;
b. only local or intra-articular injections may be administered; c. only when medically justified.
Where the rules of the governing body so provide, notification of administration may be necessary.
D. GLUCOCORTICOSTEROIDS The systemic use of glucocorticosteroids is prohibited when administered orally, rectally, or by intravenous or intramuscular injection. When medically necessary, local and intra-articular injections of glucocorticosteroids are permitted. Where the rules of the governing body so provide, notification of administration may be necessary E. BETA-BLOCKERS
Prohibited substances in class (E) include the following examples: acebutolol, alprenolol, atenolol, labetalol, metoprolol, nadolol, oxprenolol, propranolol, sotalol, . and related substances.
Where the rules of the governing body so provide, tests will be conducted for beta- blockers. IV. SUMMARY OF URINARY CONCENTRATIONS ABOVE WHICH A DOPING VIOLATION HAS OCCURED
phenylpropanolamine > 25 micrograms / millilitre
* referred to I.C.b and I.G.
SUBSTANCES AND METHODS PROHIBITED OUT-OF- COMPETITION
I.C. Anabolic I.D. Diuretics I.E.
Peptide Hormones, Mimetics and Analogues
I.G. Masking Agents II. Prohibited LIST OF EXAMPLES OF PROHIBITED SUBSTANCES AND PROHIBITED METHODS
CAUTION: This is not an exhaustive list of prohibited substances. Many substances that do not appear on this list are considered prohibited under the term "and related
substances". Athletes must ensure that any medicine, supplement, over-the-counter preparation or any other substance they use does not contain any Prohibited Substance. STIMULANTS:
DIETARY GUIDELINES FOR LAPAROSCOPIC ADJUSTABLE GASTRIC BAND SURGERY “Lap Band” (Bring this booklet to your nutrition appointments and to the hospital) Your Nutritionist: ________________________________ Telephone Number: (413) 794-7020 AN INTRODUCTION TO THE LAP BAND DIET PROGRESSION This booklet has been designed to teach you the dietary guidelines you must fo
Benefit Changes for the New Plan Year 2011/2012 Plan Year Maximum: Removal of the Plan Year benefit maximum of $500,000 , there is now no limit. Lifetime Maximum: Removal of the Lifetime benefit maximum of $1,000,000 , there is now no limit. Office Visit Co-Pay: The Plan has created an Office Visit Co-Pay. In-Network Office Visits with a BlueChoice primary-care physician will b